Qualitest Pharmaceuticals is voluntarily recalling multiple lots of birth-control pills because of a packaging error. The error could lead to incorrect dosing and possible unintended pregnancies.
The recall affects certain lots of the following pills: Cyclafem (7/7/7 and 1/35), Emoquette, Gildess FE (1.5/30 and 1/20), Orsythia, Previfem and Tri-Previfem. or a complete list of the recalled lots.
The company says the error caused the weekly tablet orientation to be reversed and obscuring the lot number and expiration date on certain packages. Essentially, select blisters were rotated 180 degrees within the card, reversing the weekly tablet orientation and making the lot number and expiry date no longer visible. Women, who do not receive the proper daily regimen of the drug, could be at risk for inadequate.
The company reports that it is investigating the source of the error. In the meantime, consumers exposed to affected packaging should begin using a nonhormonal form of contraception immediately. Pharmacies are being instructed to contact consumers who have received affected products, however, should consumers have questions or concerns, they should consult their health-care provider or pharmacist.
Earlier this month, UC Irvine’s research revealed that women who use contraceptives such as birth control pills, experience memory changes. It was reported that their ability to remember the gist of an emotional event improves, while women who do not use the contraceptives better retain the details. Despite the fact that more than 100 million women use birth control pills, there are only a handful of studies focused on cognitive effects.